InvestLog
← Back to Research← 返回研究
CVSEarnings ReleaseSource checkedSource link原始来源August 5, 2026by InvestLog AI

CVS Health Corporation (CVS) 2026 Q2 financial resultsCVS 健康 (CVS) 2026 Q2 财报发布

Key Results

CVS Health Corporation reported revenue $106.1B, operating profit $4.7B, net income $3.0B, operating margin 4.4%.

Profitability and Cash Flow

  • Period: 2026 Q2
  • Revenue: $106.1B; YoY: +7.3%
  • Operating income: $4.7B; Operating margin: 4.4%
  • Net income: $3.0B; GAAP diluted EPS: $2.31

    • Forward Guidance

    FY2026 GAAP diluted EPS $6.84–$7.04 (previously $6.24–$6.44); adjusted EPS $7.90–$8.10 (previously $7.30–$7.50); operating cash flow at least $11.5B (previously at least $9.5B).

    Official release: CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

    核心结果

    CVS 健康 公布2026 Q2财报：营收 $106.1B，营业利润 $4.7B，净利润 $3.0B，营业利润率 4.4%。

    财务指标

  • 期间：2026 Q2
  • 营收：$106.1B；同比：+7.3%
  • 经营利润：$4.7B；经营利润率：4.4%
  • 净利润：$3.0B；GAAP 稀释 EPS：$2.31

    • 前瞻指引

    2026 年 GAAP 稀释 EPS 上调至 6.84–7.04 美元（此前为 6.24–6.44 美元）；调整后 EPS 上调至 7.90–8.10 美元（此前为 7.30–7.50 美元）；经营现金流上调至至少 115 亿美元（此前至少 95 亿美元）。

    官方公告：CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

    View CVS stock details ->查看 CVS 个股详情 ->

    This earnings research was prepared from company results, regulatory filings, financial statements, and earnings-call transcripts or official replays. It is for informational purposes only and does not constitute investment advice.这篇财报研究基于公司业绩公告、监管文件、财务报表，以及财报电话会议记录或官方回放整理。内容仅供参考，不构成投资建议。